See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Diabetes

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 26.555457335788 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 26.555457335788
11046 2-NBDG New 186689-07-6 ≥98% (mixture of α and β) 2011-10-07 53.498560288221 2-nbdg NBD-Glucose fluorescence fluorescent probes glucose uptake cells viability contrast reagents neoplasia cancers diabetes flow cytometry microscopy 213484-93-6 53.498560288221
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 121.635972989564 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 121.635972989564
589320 8-hydroxy-2-deoxy Guanosine EIA Kit - 2008-05-21 619.932353985792 8-hydroxy-2-deoxy-guanosine-eia-kit 8-OH-dG ELISA Kit; DNA Damage EIA Kit solid plates oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays 619.932353985792
10012708 A-922500 959122-11-3 ≥95% 2010-12-21 258.460724370779 a-922500 (1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)-cyclopentanecarboxylic acid triglyceride obesity insulin resistance inhibitors metabolic syndrome diacyl glycerolacyltransferase DGAT-1 DGAT1 DGAT 1inhibits inhibition A-922500 A922500 mice murine diet induced obesity DIO diet-induced Compounds, Biphenyl Biphenyl Compounds 258.460724370779
10008492 Adipose Triglyceride Lipase Blocking Peptide - 2006-06-27 8.294806629834 adipose-triglyceride-lipase-blocking-peptide ATGL; TG-hydrolase inducible PLA2-ζ; Desnutrin antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis 8.294806629834
10006409 Adipose Triglyceride Lipase Polyclonal Antibody - 2005-11-23 16.582722967639 adipose-triglyceride-lipase-polyclonal-antibody Phospholipase A2ζ; Desnutrin; ATGL antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry triglycerides energy storage mammalian adipose tissues caloric excess enzymes mobilization fatty acids catalyzes triacylglycerols diacylglycerols inhibition acylhydrolase activity diabetics pathology lung skeletal muscles testis heart brain kidney cells brown fat livers murine mouse macrophages HepG2 atherosclerosis immunoblotting 16.582722967639
10010241 AICAR 2627-69-2 >98% 2008-02-25 141.414828729282 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 141.414828729282
10010332 AMP-Deoxynojirimycin Exclusive 216758-20-2 ≥95% ✓ 2008-11-21 28.911821158175 amp-deoxynojirimycin Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells 28.911821158175
580190 ANGPTL6 (human) EIA Kit New - 2012-01-10 107.686974325642 angptl6-human-eia-kit Angiopoietin-like protein 6 kits assays measures measurements angiopoietin-like proteins ANGPTLs angiopoietin-related growth factors AGF ligands regulated regulation angiogenesis glucose lipids energy metabolisms ANGPTL1 ANGPTL2 ANGPTL4 ANGPTL5 ANGPTL3 ANGPTL7 N-terminal N-terminus coiled-coil domains C-terminal C-terminus fibrinogen-like angiopoietins receptors Tie2 proteins Tie1 hepatocytes angiogenesis arteriogenesis ERK1/2-eNOS pathways transgenic mice mouse systemic expenditure high-fat diet-induced obesity ob insulin resistance null diabetic fasting serums levels immunometric sandwich plasma cells cultures supernatants 107.686974325642
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 51.080481452249 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 51.080481452249
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 55.485883977900 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 55.485883977900
10626 AS-1269574 Exclusive 330981-72-1 ≥98% ✓ 2011-01-17 15.354143646409 as-1269574 diabetes glucose insulin receptors pancrease b-cells b cells .beta.-cells beta-cells β-cells β GPR119 GPR-119 GPR 119 lysophosphatidylcholine LPC oleoylethanol amides OEA agonist Ethanolamines Aminoethanols 15.354143646409
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 29.500721085946 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 29.500721085946
10009145 Bezafibrate 41859-67-0 >98% 2007-08-02 4.529834254143 bezafibrate Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate 4.529834254143
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 7.204143646409 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 7.204143646409
71748 CAY10415 Exclusive 146062-49-9 ≥98% ✓ 2008-07-28 91.943683241252 cay10415 thiazolidinediones TZDs PPARgamma PPARg PPAR.gamma. antidiabetic anti-diabetic insulin blood glucose resistance lipogenesis peroxisome proliferators activated receptors 91.943683241252
10007875 CAY10499 Exclusive 359714-55-9 >98% ✓ 2006-07-25 9.754143646408 cay10499 obesity lipases diabetes triglycerides diacylglycerol inhibitors steroidogenesis spermatogenesis atherosclerosis HSL hormone sensitive endocrinology 9.754143646408
10009079 CAY10506 Exclusive 292615-75-9 ≥98% ✓ 2008-11-17 73.244309392265 cay10506 diabetes glucose metabolism TZDs PPARγ agonists α-lipoic acids anti-diabetic 73.244309392265
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.820911602210 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.820911602210
10009017 CAY10514 868526-38-9 >98% 2007-01-24 3.998232044199 cay10514 Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis 3.998232044199
10012562 CAY10566 944808-88-2 ≥98% 2009-01-07 48.417679558011 cay10566 SCD1 long chain fatty acids monounsaturated type 2 two diabetes dyslipidemia obesity 48.417679558011
10008846 CAY10573 Exclusive 853652-40-1 ≥98% ✓ 2009-02-02 48.666319060773 cay10573 PPARs rosiglitazone diabetes PPARα PPARδ PPARγ 48.666319060773
13143 CAY10587 Exclusive 1082058-99-8 ≥98% ✓ 2009-07-02 21.141132596685 cay10587 free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors 21.141132596685
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 47.998624923265 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 47.998624923265
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.213069367710 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.213069367710
10010250 Cellular Retinol Binding Protein 7 Polyclonal Antibody - 2007-10-16 4.740928176795 cellular-retinol-binding-protein-7-polyclonal-antibody Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry 4.740928176795
10007171 Cetaben 55986-43-1 ≥98% 2005-11-11 1.833767955800 cetaben Hexadecylamino-p-amino Benzoic Acid clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology 1.833767955800
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 26.271690607734 chenodeoxycholic-acid Hekbilin; Fluibil; Ulmenide; Kebilis; Anthropodeoxycholic Acid; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 26.271690607734
13122 CHIR99021 252917-06-9 ≥98% 2011-02-18 77.993741120757 chir99021 CT 99021 GSK-3α GSK-3β inhibitors glucose metabolism insulin diabetes Wnt stem cells mice mouse CHIR-99021 CT-99021 CHIR 99021 CT99021 pyridines glucogen synthesis CHO-IR self-renewal 77.993741120757
10006790 ChREBP Blocking Peptide - 2007-06-06 2.796284530386 chrebp-blocking-peptide WBSCR14; Carbohydrate Response Element-binding Protein proteins diseases WB western blots blotting ICC immunocytochemistry transcription factors nutrients hormonal regulations genes encoding enzymes glucose metabolisms lipogenesis pathways domains nuclear localization signals NLS N-terminus polyprolines basic tissues livers kidneys adipose basal cytosols proteins nucleus dephosphorylations mouse fat HepG2 cells 2.796284530386
10010060 ChREBP Cell-Based Translocation Assay Kit - 2007-08-15 13.247209944751 chrebp-cell-based-translocation-assay-kit Carbohydrate Response Element-Binding Protein Cell-Based Translocation Assay Kit assays kits transcription factors TFs diabetes nutrients hormones hormonal regulation genes encoding enzymes glucose metabolisms lipogenesis dephosphorylated cytoplasm protein Ser196 nucleus liver obesity tolerance drugs discovery modulators sub-cellular localization ICC immunocytochemical stains staining antibody antibodies DyLightTM Pierce Biotechnology Inc. fluorescence fluorescent fluorometric endocrinology cell-based assay cell based assay cba 13.247209944751
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 2.659116022099 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology 2.659116022099
10009753 ChREBP DBD Western Ready Control - 2007-05-03 2.261740331491 chrebp-dbd-western-ready-control Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams Beuren Syndrome Chromosome Region 14 WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology 2.261740331491
71730 Ciglitazone 74772-77-3 ≥98% 56.195560020090 ciglitazone U-63287; ADD 3878 nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology 56.195560020090
700440 Coenzyme A Assay Kit - 2011-01-19 59.023417158823 coenzyme-a-assay-kit CoA Assay Kit kits assays measures measurements coenzymes biosynthesized enzymatic pantothenate vitamin B5 cofactors acyl groups carriers carbonyl-activating TCA cycles fatty acids metabolisms acetates acetyl-CoA acetyl-coenzymes A melatonin heme rat livers diabetes fasting hypolipidemic drugs fat diets tumors plasma serum urine europium chlorides tetracyclines periodic 59.023417158823
580200 CTRP3 (human) EIA Kit New - 2012-01-20 7.292605184870 ctrp3-human-eia-kit Complement C1q TNF-related Protein 3 kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants 7.292605184870
580120 CTRP5 (human) EIA Kit - 2011-08-02 14.119686157151 ctrp5-human-eia-kit C1QTNF; C1q tumor necrosis factor-α-related proteins C1q/tumors necrosis factors 5 superfamily genes untranslated membranes frizzled-related proteins MFRP bicistronic transcript mutations late-onset retinal degeneration LORD apical basal pigmented epithelium ciliary tissues neuroectodermal macular adipose blood glycoproteins trimers oligomeric complexes disulfide bonds N-terminal N-terminus cysteine residues extracellular recombinant activator adenosine monophosphates AMP-activated kinases AMPK cells GLUT4 glucose uptake serum obese diabetic mice mouse competitive plasma assays kits measures measurements EIAs ELISAs enzymes immunoassays 14.119686157151
700520 D-Lactate Assay Kit - 2011-02-23 74.465604276153 d-lactate-assay-kit kits assays measures measurements D(-)-Lactates stereoisomers blood exogenous fermented foods yogurt sauerkraut pickles gastrointestinal tract lactobacilli bifidobacteria cytosols cells glyoxylase I II pathways methylglyoxal glutathione S-D-lactoylglutathione L-lactate L(+)-lactate pyruvates dehydrogenases LDH liver D-a-hydroxy acid D-alpha-hydroxy D-α-hydroxy mammals enzymes humans murines mitochondrial mitochondria D-lactic acidosis metabolic serum neurotoxic fermentation carbohydrates kidneys short bowel syndromes jejunoileal bypass surgery diabetes infection ischemia trauma monogastric malabsorptive nutrient sepsis plasma urine saliva intracellular extracellular cell culture samples oxidation reduction NAD+ NADH 74.465604276153
700210 DPP (IV) Inhibitor Screening Assay Kit - 2009-05-27 101.732861418047 dpp-iv-inhibitor-screening-assay-kit Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC 101.732861418047
500480 dsDNA Autoantibody (human) EIA Kit New - 2011-10-07 7.086614173228 dsdna-autoantibody-human-eia-kit Anti-double stranded DNA EIA EIAs ELISAs enzymes immunoassays kits measures measurement autoimmunity neutrophils extracellular traps NETs histones peptides deoxyribonucleic acids DNAse I-mediated DNA-degrading plasma systemic lupus erythematosus SLE autoantibodies double stranded dsDNA IgG anti-dsDNA autoimmune diseases immunometric isotypes human serum affinity-purified antibody calf thymus poly-L-lysine protamine sulfate 7.086614173228
10011296 (E)-Guggulsterone 39025-24-6 ≥98% 2009-12-03 0.966850828729 -e-guggulsterone anti-flammatory cancers FXR bile acids LDL cholesterol antiinflammatory atherosclerosis obesity diabetes inflammation farnesoid X receptors guggul trees 0.966850828729
10008884 Eicosapentaenoic Acid ethyl ester 86227-47-6 ≥98% 2009-01-29 56.566645930308 eicosapentaenoic-acid-ethyl-ester EPA-EE; EPA ethyl ester fish oils anti-inflammatory anitinflammatory cardiovascular polyunsaturated fatty acids PUFAs EPAs nutrition oxidation competitive inhibitors inhibits inhibition metabolism cholesterol triglycerides insulin resistance adiponectin high fat diet high-fat TNFα 56.566645930308
10010019 FABP2 Polyclonal Antibody - 2007-10-02 22.575615627466 fabp2-polyclonal-antibody I-FABP; Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2 WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 22.575615627466
10009549 FABP4 (human recombinant) - >90% 2007-06-15 30.360148746281 fabp4-human-recombinant Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; A-FABP; Adipocyte Fatty Acid Binding Protein; aP2 cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 30.360148746281
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.106180939226 fabp4-human-recombinant-western-ready-control Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.106180939226
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 10.065867403314 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 10.065867403314
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 4.295814917127 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 4.295814917127
10004888 FMOC-L-Leucine 35661-60-0 ≥98% 2010-07-19 36.510713982150 fmoc-l-leucine FMOC-Leu; NPC 15199; NSC 334290 peroxisome proliferator-activated proliferator activated receptors activates PPAR PPARg PPAR-g PPARgamma PPAR.gamma. PPAR-gamma PPAR-.gamma. PPARγ PPAR-γ PPAR γ adipocytes differentiation fatty acids uptake glucose metabolism agonist partial insulin resistance diabetes adipogenesis NPC15199 NSC334290 NPC-15199 NSC-334290 Leucine L-Isomer Leucine L Isomer L-Isomer Leucine L-LeucineLeucine 36.510713982150
700310 Free Fatty Acid Assay Kit - 2010-09-08 109.454098904597 free-fatty-acid-assay-kit FFA kits assays measures measurements acids triglycerides intestines hydrolyzed glycerols enzymes pancreas pancreatic lipases intestinal liposomes capillaries lymph systems blood plasmas serums hepatocytes adipocytes muscles fibers oxidized sugars glucagon fats proteins albumin FFA skeletal skeletons hearts livers pathophysiological obesity insulin resistance type 2 II diabetes pathogenesis insulin-stimulated peripheral glucose uptake beta cells oxidative stressproinflammatory effects NFκB nuclear factors inflammation resistances metabolic urine enzymatic reactions Acyl CoA synthetase ACS acylation coenzymes oxidases ACOD hydrogen peroxides H2O2 horseradish peroxidases HRP 10-aceyl-3,7-dihydroxyphenozazine ADHP fluorescence fluorescent resorufins 109.454098904597
11104 Fructose 1,6-bisphosphatase (human recombinant) New - ≥95% 2011-11-29 78.492511590196 fructose-1-6-bisphosphatase-human-recombinant FDPase; FBP1; F1,6BPase metabolism insulin non-insulin-dependent type 2 diabetes mellitus glucose kinases fructose 1,6-diphosphatase liver enzymes gluconeogenesis phosphofructokinase glycolysis lactate glycerol alanine NIDDM hyperglycemia 78.492511590196
10816 FTO (human) Monoclonal Antibody (Clone FT 86-4) - 2011-06-15 0E-12 fto-human-monoclonal-antibody-clone-ft-86-4 Fat Mass- and Obesity-associated Protein; FATSO antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP genes mutation metabolic syndrome genotype type 2 diabetes FT 864 FT864 0E-12
10815 FTO (mouse) Monoclonal Antibody (Clone FT 342-1) - 2011-06-15 0E-12 fto-mouse-monoclonal-antibody-clone-ft-342-1 Fat Mass- and Obesity-associated Protein; FATSO antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay mouse mice genes mutation metabolic genotype type 2 diabetes FT 3421 syndrome FT3421 0E-12
10814 FTO (murine) Monoclonal Antibody (Clone FT 62-6) - 2011-06-14 0E-12 fto-murine-monoclonal-antibody-clone-ft-62-6 FATSO; Fat Mass- and Obesity-associated Protein antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP mouse mice genes mutation metabolic genotype type 2 diabetes syndrome FT 626 FT626 0E-12
13068 Fucoxanthin Exclusive 3351-86-8 ≥98 ✓ 2010-01-29 13.783314917126 fucoxanthin α-Carotene carotenoids algae white adipose tissues WAT obesity weight gain uncoupling proteins 1 UCP1 thermogenesis diabetes type 2 glucose insulin all-trans Carotenoids Xanthophyll Xanthophyll Carotenoids Xanthophyllshyperinsulinemia 13.783314917126
10010622 Genipin 6902-77-8 ≥98% 2008-05-09 99.322569060774 genipin (+)-Genipin obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity 99.322569060774
10990 Glucokinase (human liver recombinant) New - ≥85% 2011-09-08 46.668330263965 glucokinase-human-liver-recombinant Human Hexokinase IV isoform 2; Hexokinase D; ATP:D-Hexose 6-Phosphotransferase GCK metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations 46.668330263965
10989 Glucokinase (human pancreatic recombinant) New - ≥90% 2011-09-08 48.557219152854 glucokinase-human-pancreatic-recombinant Hexokinase D; ATP:D-Hexose 6-Phosphotransferase GCK; Human Hexokinase IV isoform 1 metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases GCK ATP-dependent phosphorylation glycolytic liver tissues neurons pancreatic cells pituitary endocrine hexokinases mutations 48.557219152854
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 88.633117496585 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH Activity Assay Kit kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 88.633117496585
10009582 Glucose Assay Kit - 2007-06-11 173.837822271914 glucose-assay-kit assays kits monosaccharides simple sugars carbohydrates blood stream energy cells hyperglycemia hypoglycemia Diabetes mellitus oxidase-peroxide d-gluconolactone delta-gluconolactone .delta.-gluconolactone plasma serum urine endocrinology 173.837822271914
600470 Glucose Uptake Cell-Based Assay Kit New - 2011-12-14 103.757944371315 glucose-uptake-cell-based-assay-kit assay kits measuring measurement CBAs C6H12O6 energy metabolisms adenosines triphosphates ATP cells homeostasis intestines blood muscles liver glycogens hydrolyzed levels transporters concentrations gradients energy-dependent uptakes gut kidneys rate hormones human growth factors insulin proliferation atrophy cancers pathways aerobic glycolysis anti-cancer effects drugs discovery fluorescent analogs 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose 2-NBDG modulators cellular deoxyglucose cultured apigenin flavonoid 103.757944371315
700720 Glycerol Fluorometric Assay Kit New - 2012-01-17 121.085717306741 glycerol-fluorometric-assay-kit assays kits measures measurements flourometer fluorometry triglycerides storage fats metabolites energy metabolisms oxidations physiological pathological hydrolyzed free fatty acids FFAs blood glucose sugar gluconeogenesis lipolysis serums concentrations kinases x-linked inborn hyperglycerolemia glyceroluria fluorescence-based plasma phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 121.085717306741
700480 Glycogen Assay Kit - 2011-08-02 78.053299606376 glycogen-assay-kit kits assays measures measurements polysaccharides storage glucose animal human cells polymers alpha(1,4) .alpha.(1,4) α(1,4) linkages units backbones livers muscles glycogenesis glycolysis brains stomachs granules cytosols cycles hepatocytes source available glucose-6-phosphatases blood kidneys glial WBCs white uterus pregnancy embryo abnormal metabolisms diabetes mellitus synthesis storage diseases von Gierke's Pompe McArdle's tissues hydrolyzed hydrolysis amyloglucosidases .beta.-D-glucose beta-D-glucose β-D-glucose oxidized oxidases hydrogen peroxides H2O2 horseradish peroxidases HRP 10-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 78.053299606376
10007206 GPR40 Blocking Peptide - 2007-04-12 2.269558011050 gpr40-blocking-peptide immunohistochemistry peptide insulin diabetes breast cancer 2.269558011050
10007205 GPR40 Polyclonal Antibody - 2007-04-04 14.011123388582 gpr40-polyclonal-antibody Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC 14.011123388582
10009374 GSK3β (Phospho-Ser9) Polyclonal Antibody - 2006-11-13 2.284505831798 gsk3-phospho-ser9-polyclonal-antibody Anti-Phospho-Ser9 Glycogen Synthase Kinase 3β antibodies proteins diseases antibodies antisera antiserum WB western blots blotting serine/threonine kinases regulation regulates signaling pathways GSK3a GSK3alpha GSK3.alpha. GSK3b GSK3beta inhibitors inhibition inhibits insulin Wnt Ser9 phosphorylation phospho-specific immunoblotting 2.284505831798
10008907 GW 9508 885101-89-3 ≥98% 2007-05-14 37.349516574586 gw-9508 agonists GPR40 GPR120 G protein receptors fatty acid glucose insulin MIN6 coupled endocrinology GW9508 37.349516574586
10011211 GW 9578 Exclusive 247923-29-1 ≥98% ✓ 2008-05-23 23.362681682957 gw-9578 atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated 23.362681682957
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
10010324 Harmine 442-51-3 ≥98% 2007-11-07 24.470236266450 harmine metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology 24.470236266450
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 131.388888888888
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 77.222222222222 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 77.222222222222
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 131.388888888888
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 134.722222222222 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 134.722222222222
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 143.055555555555 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 143.055555555555
500340 Human Serum Albumin EIA Kit - 2009-07-16 105.600950276243 human-serum-albumin-eia-kit Albumin (human serum) EIA Kit; HSA ELISA Kit solid plates EIAs ELISAs enzymes immunoassays kits measures measurement renal kidneys blood proteins serums osmotic pressure buffering pH hormones fatty acids transports transportation microaluminuria macroalbuminuria disease non-diabetic nephropathy cardiovascular morbidity mortality creatinine assays 105.600950276243
10010676 Hydrochlorothiazide-d2 15N2 - ≥99% deuterated product 2009-05-02 0E-12 hydrochlorothiazide-d2-15n2 58-93-5 8049-49-8 125727-50-6 edema hypertension diabetes deuterated deuterium 0E-12
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.545248618785 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 2.545248618785
10010785 (±)-Lisofylline 6493-06-7 ≥98% 2009-09-18 17.697113259669 -lisofylline CT-1501R; BL 194; LSF pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 17.697113259669
700510 L-Lactate Assay Kit - 2011-02-21 115.792285905363 l-lactate-assay-kit kits assays measures measurements L(+)-lactates stereoisomers humans metabolisms pyruvates ratios redox reduction oxidation cells NAD+ NADH dehydrogenases LDH glycolysis oxygen Cori cycles livers monocarboxylates tissues skeletal cardiac muscles kidneys substrates feedback inhibition lactic acidosis exercise convulsions sepsis respiratory failure HIV cancers diabetes serum plasma blood urine saliva intracellular extracellular cell culture samples 115.792285905363
10010236 ML-9 105637-50-1 ≥98% 2008-01-21 16.362486187845 ml-9 PKB Akt inhibitors inhibits inhibition serine/threonine kinase PKA P90S6 MAP kinases cancers anti-cancers insulin glucose transports calcium channels calmodulin intracellular smooth muscles asthma 16.362486187845
10009661 N-Octadecyl-N'-propyl-sulfamide - >95% 2008-04-23 5.341961325967 n-octadecyl-n-propyl-sulfamide PPAR.alpha. PPARa PPARalpha OEA satiety obesity metabolism food intake triglyceride lipids activators appetite suppression 5.341961325967
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
13804 OU749 519170-13-9 ≥95% 2010-07-20 1.839779005525 ou749 γ-Glutamyl transferases γ-glutamyl transpeptidases glutathione markers liver dysfunction alcohol abuses biomarkers diabetes cardiovascular diseases cancers acivicin OU-749 OU 749 Mixtures Sulfonamide Sulfonamide Mixtures Sulfonamides 1.839779005525
10010374 p38 MAPK (Phospho-Thr180/Tyr182) Cell-Based Phosphorylation/Translocation Assay Kit - 2007-09-17 2.067087608524 p38-mapk-phospho-thr180-tyr182-cell-based-phosphorylation-translocation-assay-kit phosphorylation kits assays enzymes diseases asthma autoimmunity stress response nervous system fluorescence fluorescent fluorometric 2.067087608524
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 13.274198895027 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 13.274198895027
10010254 Pentosidine 124505-87-9 ≥98% 2011-02-10 19.966132596685 pentosidine advanced glycation end products AGEs RAGE glycosylation diabetes uremia aging rheumatic arthritis biomarkers 19.966132596685
10004943 PEPCK Polyclonal Antibody - 2005-08-03 37.308718232043 pepck-polyclonal-antibody Phosphoenolpyruvate carboxykinase; PEPCK-c; Pck1 proteins antibodies antisera antiserum WB western blots blotting hormones regulates enzymes steps gluconeogenesis catalyzing conversions oxaloacetate phosphoenolpyruvate mRNA liver kidney cortex white adipose tissue brown fat mammary gland lactation small intestine non-insulin-dependent diabetes mellitus streptozotocin-induced elevated activity isozymes cytosolic mitochondrial murine mouse rat endocrinology immunoblotting 37.308718232043
301707 PGC-1 Blocking Peptide - 2006-07-25 16.098563535912 pgc-1-blocking-peptide antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases proteins peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity 16.098563535912
101707 PGC-1 Polyclonal Antibody - 2005-10-12 29.541506780512 pgc-1-polyclonal-antibody PPARγ Coactivator 1; Peroxisome Proliferator-activated Receptor γ Coactivator 1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry peroxisomes receptors gamma .gamma. PGC-1.beta. PGC-1.alpha. PRC N- C-terminus inducible transcriptional nuclear energy hepatic gluconeogenesis cholesterol homeostasis activates oxidative metabolisms tissues kidneys heart brown adipose skeletal muscles metabolic disorders type II 2 diabetes obesity endocrinology immunoblotting 29.541506780512
71745 Pioglitazone 111025-46-8 >98% 43.330260457774 pioglitazone PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated rosiglitazone receptors activation selectively selectivity 43.330260457774
10028 Pioglitazone (potassium salt) - >98% 52.518184688240 pioglitazone-potassium-salt PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated receptors 52.518184688240
13643 PP242 1092351-67-1 ≥95% 2011-04-22 23.734631237393 pp242 mTORs mTORC1 mTORC2 inhibitors cancer leukemia rapamycin PP 242 PP-242 inhibited inhibition 23.734631237393
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 28.164267955801 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 28.164267955801
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 21.181080417433 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 21.181080417433
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 61.004459352801 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 61.004459352801
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.257910597690 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.257910597690
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 19.116820135051 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 19.116820135051
10006247 PPARδ Blocking Peptide - >70% 2004-11-09 4.339226519337 ppar-blocking-peptide PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 4.339226519337
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 11.494211172498 ppar-human-recombinant PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 11.494211172498
101720 PPARδ Polyclonal Antibody - 2004-11-05 18.859161225514 ppar-polyclonal-antibody Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies 18.859161225514
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 34.272707182320 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 34.272707182320
13346 Rapamycin 53123-88-9 ≥95% 2009-10-21 71.548611281632 rapamycin Sirolimus immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases 71.548611281632
579070 Retinol Binding Protein 4 (human) Competitive EIA Kit - 2011-08-01 7.292605184870 retinol-binding-protein-4-human-competitive-eia-kit RBP4 binding proteins EIAs ELISAs enzymes immunoassays kits measures measurement insulin glucose homeostasis uptake skeletal muscles adipose tissues transporter 4 GLUT4 resistance vitamins A adipokines metabolic obesity syndromes cardiovascular diseases expression pro-inflammatory cytokines LDLs low-density lipoproteins cholesterols diet-induced obese hyperlipidemic hyperlipidemia dyslipidemia lipids metabolisms serums plasmas disorders 7.292605184870
13616 (R)-Lisofylline 100324-81-0 ≥98% 2010-05-27 1.784944751381 -r-lisofylline (R)-LSF; (-)-Lisofylline pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma 1.784944751381
13300 Ro 31-6045 113963-68-1 ≥98% 2009-07-28 4.563674033149 ro-31-6045 Bisindolylmaleimide V PKC kinase inhibitors S6K mitogen-stimulated proteins p70 p85 protein kinases C 4.563674033149
71740 Rosiglitazone 122320-73-4 >98% 142.434901341752 rosiglitazone BRL 49653 BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology 142.434901341752
10011343 Rosiglitazone-d5 Maleate - >99% deuterated product 2009-04-04 39.880375690608 rosiglitazone-d5-maleate SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory 39.880375690608
71742 Rosiglitazone (potassium salt) 316371-84-3 >98% 99.240115519839 rosiglitazone-potassium-salt BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology 99.240115519839
10010247 SB 415286 264218-23-7 ≥98% 2008-10-29 8.976077348066 sb-415286 GSK3 GSK-3 PI3K signaling PI3K signalling glycogen synthase inhibitors inhibits inhibition neuron survival glycogen synthesis Chang human liver cells line potent selective sb415286 8.976077348066
10007682 Serum Retinol Binding Protein 4 Blocking Peptide - 2007-07-30 0E-12 serum-retinol-binding-protein-4-blocking-peptide pRBP Blocking Peptide; Plasma Retinol Binding Protein 4 Blocking Peptide; sRBP4 Blocking Peptide wb western blotting TTR serum type 2 diabetes sRBP plasma SRBP-4 blots proteins serums retinols insulin special:month specialdiscount:15 specialstart:2007-08-01 specialend:2007-09-30 RBP 0E-12
10007818 Serum Retinol Binding Protein 4 (human recombinant) - ≥95% 2006-10-05 14.817995264404 serum-retinol-binding-protein-4-human-recombinant RBP4; sRBP4 proteins vitamin A blood mammals .beta.-sheet-rich lipocalins hepatocytes plasma tetrameric transthyretin TTR adipocyte-derived adipocytes signaling type 2 diabetes insulin C-terminal terminus hexahistidine tag endocrinology 14.817995264404
10007681 Serum Retinol Binding Protein 4 Polyclonal Antibody Exclusive - ✓ 2007-08-03 3.454220994475 serum-retinol-binding-protein-4-polyclonal-antibody Plasma Retinol Binding Protein 4; pRBP; sRBP4 vitamin A wb western blotting type 2 diabetes lipocalin TTR transthyretin sRBP4 sRBP-4 proteins adipocytes signals signalling signaling insulin blots retinols serums RBP atherosclerosis endocrinology immunoblotting 3.454220994475
10009754 Serum Retinol Binding Protein Western Ready Control Exclusive - ✓ 2008-07-08 0E-12 serum-retinol-binding-protein-western-ready-control sRBP4; RBP4 proteins C-terminal western blots immunoblotting WB SRBPs hexahistidine His-tag His-tagged insulin resistance tyep 2 diabetes pathogenesis blotting 0E-12
13617 (S)-Lisofylline Exclusive 100324-80-9 ≥98% ✓ 2010-05-27 1.493646408840 -s-lisofylline (S)-LSF; (+)-Lisofylline pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed 1.493646408840
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 22.916324432167 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions 22.916324432167
10009239 SREBP-2 Cell-Based Translocation Assay Kit - 2007-04-17 33.059637814609 srebp-2-cell-based-translocation-assay-kit Sterol Regulatory Element-Binding Protein-2 Cell-Based Translocation Assay Kit sterol regulatory element binding proteins athersclerosis cholesterols fatty acids triglycerides phospholipids helix-loop-helix HLH transcription factors DyLight Pierce Biotechnology assays fluorescence fluorescent fluorometric cell-based assays cell based assay cba U18666A U 18666A U-18666A 33.059637814609
10009749 SREBP-2 Western Ready Control - 94 kDa (GST-tagged); 68 kDa (native) 2007-07-30 15.195226519336 srebp-2-western-ready-control Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2 WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis 15.195226519336
10026 T0070907 313516-66-4 >98% 65.236381215470 t0070907 T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology 65.236381215470
10010303 Triglyceride Colorimetric Assay Kit - 2007-10-31 273.486091224874 triglyceride-colorimetric-assay-kit assays kits triglycerides enzymes enzymatic hydrolysis water-insoluble lipids three fatty acids esterified glycerols blood serums lipoproteins chylomicrons very low density VLDLs dietary fats metabolisms energy diagnosis primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstruction endocrine colorimetric fluorometric plasmas coupled reaction systems 273.486091224874
700730 Triglyceride Fluorometric Assay Kit New - 2012-01-17 126.316138735420 triglyceride-fluorometric-assay-kit assays kits measures measurements flourometer fluorometry triglycerides water-insoluble lipids fatty acids esterified glycerols blood lipoproteins chylomicrons very low-density VLDLs dietary fats hydrolyzed hydrolysis free FFAs monoglycerides diglycerides intestines intestinal villi guts resynthesized capillary beds lipases adipose tissues storage stream oxidized mitrochondrias peroxisomes energy metabolisms levels lipids primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstructions endocrine disorders enzymatic hydrolysis fluorescence-based plasmas serums phosphorylated glycerol-3-phosphates G-3-P adenosine-5'-diphosphates ADP oxidized phosphates oxidases dihydroxyacetones hydrogen peroxides H2O2 horseradish HRPs 1-acetyl-3,7-dihydroxyphenoxazine ADHP resorufin 126.316138735420
71750 Troglitazone 97322-87-7 >98% 165.226773480663 troglitazone ResulinTM antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology 165.226773480663
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.160220994475 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.160220994475
700320 Uric Acid Assay Kit - 2010-08-30 118.175530072317 uric-acid-assay-kit Urate Assay Kit kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia 118.175530072317
579000 Vaspin (human) EIA Kit - 2011-05-26 26.793871291180 vaspin-human-eia-kit Visceral Adipose Tissue-Derived Serpin A12 kits measures measurements EIA enzymes immunoassays adipokines insulin-sensitizing cDNA deoxyribonucleic acids white adipose tissues obese Otsuka Long Evans Tokushima Fatty OLETF rats absominal obesity type 2 diabetes serpins b-sheets beta-sheets β-sheets α-helices a-helices alpha-helices reactive site loops cognate serine proteases mRNA messenger ribonucleic visceral serum resistance pioglitazone biomarker plasma cells culture supernatants 26.793871291180
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 43.700611040279 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 43.700611040279
13576 YM-201636 371942-69-7 ≥95% 2010-04-14 6.107066298342 ym-201636 PIKfyve phosphoinositide kinase PIK zinc finger domains phosphatidylinositol 3-phosphate PI3P PI(3,5)P2 membrane trafficking cytoskeleton inhibitors endosomal trafficking endosomes phagocytosis retrovirus virology adipocytes insulin glucose diabetes YM201636 YM 201636 Aminopyridines 6.107066298342
10009992 Zeaxanthin 144-68-3 ≥98% 2009-02-02 19.561123388581 zeaxanthin Zeaxanthol; Xanthophyll 3; Anchovyxanthin carotenoid degeneration AMDs luteins diabetes antioxidant oxidative injury injuries VEGFs macula 19.561123388581
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.489963167587 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.489963167587
700190 β-Hydroxybutyrate (Ketone Body) Assay Kit - 2009-06-02 157.381613542995 -hydroxybutyrate-ketone-body-assay-kit β-HB Assay Kit; 3-Hydroxybutyric Acid Assay Kit .beta.-hydroxybutyrate beta-hydroxybutyrate b-hydroxybutyrate b-HB beta-HB .beta.-HB β-HB 3-hydroxybutyric acids ketones body bodies acetoacetates acetones ketosis lipids metabolisms fasting exercise diets diabetes childhood hypoglycemia corticosteroids growth hormones deficiency intoxication alcohols salicylates organ failure ketoacidosis metabolic acidosis blood serums subclinical glucose diabetic coma hyperosmolar non-ketotic insulin hyperketonemia neurodegenerative diseases inhibits inhibition adipocytes lipolysis plasmas urine assays 157.381613542995
10007602 Δ2-cis Eicosenoic Acid 93772-82-8 ≥98% 2006-01-04 0E-12 -2-cis-eicosenoic-acid .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-trans D2 extracted fresh wateer clams medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats 0E-12
10007622 Δ2-trans Eicosenoic Acid - ≥98% 2006-01-04 0E-12 -2-trans-eicosenoic-acid .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-cis D2 medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats 0E-12
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?